Strength
10 mg/mL
Manufacturer
Hospira Inc.NDC
00409146301
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
Last Updated
3/18/2026
Active Ingredients
NALBUPHINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA070914On Market Since
6/27/2008
Pharmacological Classes
Related Drugs
Same classification
BUPRENORPHINE 2 MG TABLET SL
Generic
00054017613•Hikma Pharmaceuticals USA Inc.
$0.2676
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
00121101930•PAI Holdings LLC
$0.2676
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
00228315603•Actavis Pharma, Inc.
$0.2676
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
00904715404•Major Pharmaceuticals
$0.2676
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
42858050103•Rhodes Pharmaceuticals L.P.
$0.2676
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
50268012815•AvPAK
$0.2676
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
60687048121•American Health Packaging
$0.2676
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
62756045983•Sun Pharmaceutical Industries Inc.
$0.2676
per EA
BUPRENORPHINE 2 MG TABLET SL
Generic
72888018230•Advagen Pharma Ltd.
$0.2676
per EA
BUPRENORPHINE-NALOXONE 2-0.5 MG SL TABLET
Generic
00054018813•Hikma Pharmaceuticals USA Inc.
$0.4698
per EA